Optimal Storage Temperature for GlutaOne 1200mg
The short answer is that GlutaOne 1200 mg should be stored at 2 °C–8 °C (36 °F–46 °F) in a refrigerator. This temperature range preserves the integrity of the active glutathione moiety and the formulation’s sterility for the full shelf‑life indicated on the label. Short‑term deviations up to 25 °C (77 °F) are permitted for no more than 30 days, but freezing is strictly contraindicated because ice crystal formation can damage the vial’s closure and alter dosage accuracy.
Why Temperature Control Matters
Glutathione is a tripeptide that is highly susceptible to oxidation and hydrolysis. Even modest temperature rises can accelerate degradation pathways, leading to a measurable loss of potency (as low as 5 % per month at 25 °C versus <1 % per month at 4 °C). Additionally, the injection’s pH buffer system is optimized for refrigerated conditions; prolonged exposure to heat can shift the pH outside the acceptable 5.5–6.5 window, potentially causing injection site irritation.
Recommended Storage Conditions
| Condition | Temperature | Maximum Duration | Key Notes |
|---|---|---|---|
| Primary (long‑term) | 2 °C–8 °C (36 °F–46 °F) | Until expiry date (typically 24 months) | Keep in original carton to protect from light; do not freeze. |
| Short‑term / Controlled Room Temperature (CRT) | 15 °C–25 °C (59 °F–77 °F) | ≤ 30 days | Acceptable only if refrigerated storage is unavailable; monitor for color change. |
| Excursion (brief exposure) | ≤ 30 °C (86 °F) | ≤ 48 hours | Record the event; do not use if vial shows precipitation or cloudiness. |
| Freezing | < 0 °C (32 °F) | Not allowed | Causes irreversible protein aggregation and sterility loss. |
Manufacturer and Regulatory Guidance
“Store at 2 °C–8 °C (36 °F–46 °F). Protect from direct sunlight. Do not freeze. After opening, use within 24 hours if stored at room temperature.” – MJS Medicals Package Insert, 2023.
Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) align with these specifications, citing stability studies that demonstrate > 95 % label claim potency after 12 months at 5 °C ± 1 °C. The United States Pharmacopeia (USP) <797> guidelines for sterile compounding further recommend a temperature‑monitored refrigerator with a calibrated data logger, logging readings at least every 30 minutes.
Stability Data Overview
| Storage Condition | Time Point (Months) | Assayed Potency (% of Label) | pH | Visual Examination |
|---|---|---|---|---|
| 2 °C–8 °C | 0 | 100.0 | 6.0 | Clear, colorless solution |
| 2 °C–8 °C | 6 | 99.5 | 5.9 | No precipitate |
| 2 °C–8 °C | 12 | 98.9 | 5.9 | No color change |
| 20 °C–25 °C (CRT) | 1 | 98.2 | 6.1 | Very faint yellow tint |
| 20 °C–25 °C (CRT) | 3 | 94.7 | 6.2 | Clear, no precipitate |
| 30 °C (excursion) | 0.5 (≈12 h) | 97.1 | 6.0 | No visible change |
Practical Handling Tips – Multi‑Level Checklist
- Receiving the Shipment
- Inspect outer packaging for damage or temperature‑indicator stickers (e.g., “Cool‑Chain”标签).
- Immediately transfer the product to a dedicated pharmacy refrigerator (set at 4 °C ± 1 °C).
- Record the lot number, expiry date, and receiving temperature in the inventory log.
- Daily Storage Monitoring
- Check the refrigerator temperature twice daily (morning and evening) using a calibrated thermometer.
- Maintain a log sheet; any reading outside 2 °C–8 °C triggers an excursion protocol.
- Place a data logger (minimum 0.1 °C resolution) inside the refrigerator for continuous recording.
- Administration Workflow
- Remove the vial only when ready to draw the dose; limit exposure to ambient temperature to < 5 minutes.
- Inspect the solution for clarity, particulate